Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Clinical Neurology,Biochemistry
Reference22 articles.
1. Abid S, Jafri W, Mumtaz K, Islam M, Abbas Z, Shah HA, Hamid S (2011) Efficacy of L-ornithine L-aspartate as an adjuvant therapy in cirrhotic patients with hepatic encephalopathy. J Coll Physicians Surg Pak 21(11):666–671. https://doi.org/11.2011/JCPSP.666671
2. Alvares-da-Silva MR, DE Araujo A, Vicenzi JR, Veber da Silva G, Oliviera FB, Schacher F et al (2014) Oral L-ornithine L-aspartate in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled trial. Hepatol Res 44(9):956–963.
https://doi.org/10.1111/hepr.12235
3. Bai M, He C, Yin Z, Niu J, Wang Z, Qi X et al (2014) Randomised clinical trial: L-ornithine L-aspartate reduces significantly the increase of venous ammonia concentration after TIPSS. Aliment Pharmacol Ther 40:63–71.
https://doi.org/10.1111/apt.12795
4. Butterworth RF (2019) Hepatic encephalopathy in cirrhosis: pathology and pathophysiology. Drugs 79(Suppl 1): 17.
https://doi.org/10.1007/s40265-018-1017-0
5. Butterworth RF, Canbay A (2019) Hepatoprotection by L-ornithine L-aspartate in non-alcoholic fatty liver disease. Dig Dis 37:63–68.
https://doi.org/10.1159/000491429
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献